Abstract
Peritoneal dialysis (PD) can be a simple and convenient, safe and effective home treatment, and has become an alternative treatment for end-stage renal disease. China is the most populous country, and the number of PD patients continued to rise in recent years with both the popularity of urban and rural basic medical insurance system and the national health policy control. PD in China is facing new opportunities and challenges, and it is imperative to pay attention to clinical technological improvements and scientific research and exploration of PD in China. The present editorial aimed to introduce the situation and challenge of PD in China, optimize the individualized PD treatment regimen for Chinese patients in order to improve the quality of treatment by evidence-based medicine, strengthen the management of quality control, strive to build PD treatment homogeneity, consolidate PD research foundation, and expand the product area of PD-related independent intellectual property, so as to provide new thoughts for clinical and basic research on PD to get greater social and economic benefits. Key words: Peritoneal dialysis; End-stage renal disease; Continuous ambulatory peritoneal dialysis
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
